Code

M13-098//2012-002035-29


Promoter

Abbott GmbH & Co. KG


Pathology and candidate patients

Hepatitis


Medical equipment

Dr. Moises Diago

Hospital Quirónsalud Valencia.



Study status

Active


Test product

ABT450 / ritonavir / ABT-267 and ABT-333 administered together with ribavirin (RBV)


Date CEIC

June 11, 2013


CEIC

Hospital Quirónsalud valencia



Contact

If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment.
You can request a consultation with the cardiology team by sending an email to the address: info.valencia@quironsalud.es